Biotech
Doctors Back New Moderna and Merck Cancer Vaccine
Cancer doctors praise new vaccine data from Moderna and Merck despite a cool reaction from Wall Street.

Skin cancer patients have new reason for hope today. Doctors see a big leap forward in fighting deadly melanoma.
Moderna and Merck teamed up to test a new cancer shot. Six top skin cancer doctors reviewed the trial results. They say the medicine helps patients stay cancer-free after surgery.
Wall Street traders wanted bigger numbers. Stocks slipped after the news broke. Medical experts disagree with the market doubt. They call the treatment a major step forward for medicine.
This shot teaches the body to hunt cancer cells. It gives families a stronger path to recovery. Medical progress moves forward even when stock prices swing.
Source: CNBC
#Biotech#Moderna#Merck#Cancer Research#Stock Market




